Association of Urinary Phthalate Metabolites with All-cause and Cardiovascular Disease Mortality Among Adults with Diabetes Mellitus: National Health and Nutrition Examination Survey 2005-2014

Overview

Journal Front Public Health

Specialty Public Health

Date 2023 Jun 16

PMID 37325320

Authors

Zhihong Wang

Yao Deng

Sikang Gao

Zefang Lin

Zhixiong Zheng

Qin Fang

Meixiao Zhan

Taoping Sun

Guomin Huang

Xuyang Geng

Affiliations

Soon will be listed here.

Abstract

Background: The study regarding phthalate metabolites and mortality among diabetes mellitus (DM) is limited. We aimed to examine the association of urinary phthalate metabolites with all-cause and cardiovascular disease (CVD) mortality among adults with DM.

Methods: This study included 8,931 adults from the National Health and Nutrition Examination Survey (NHANES) from 2005-2006 to 2013-2014. Mortality data were linked to National Death Index public access files through December 31, 2015. Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidences (CIs) for mortality.

Results: We identified 1,603 adults with DM [mean ± SE age, 47.08 ± 0.30 years; 50.5% (833) were men]. Mono-(carboxynonyl) phthalate (MCNP), mono-2-ethyl-5-carboxypentyl phthalate (MECPP), and the sum of Di (2-ethylhexyl) phthalate (DEHP) metabolites (∑DEHP) were positively associated with DM (MCNP: OR = 1.53, 95%CI = 1.16-2.01; MECPP: OR = 1.17, 95% CI = 1.03-1.32; ∑DEHP: OR = 1.14, 95% CI = 1.00-1.29). Among DM patients, mono-(3-carboxypropyl) phthalate (MCPP) was associated with a 34% (HR 1.34, 95% CI 1.12-1.61) increased risk of all-cause mortality while the HRs (95%CI) of CVD mortality were 2.02 (1.13-3.64) for MCPP, 2.17 (1.26-3.75) for mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), 2.47 (1.43-4.28) for mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), 2.65 (1.51-4.63) for MECPP, and 2.56 (1.46-4.46) for ∑DEHP, respectively.

Conclusion: This study is an academic exploration of the association between urinary phthalate metabolites and mortality among adults with DM, suggesting that exposure to phthalates might be associated with an increased risk of all-cause and CVD mortality in DM. These findings suggest that patients with DM should carefully use plastics products.

References

Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9):829-841. PMC: 4109980. DOI: 10.1056/NEJMoa1008862. View

Duan Y, Wang L, Han L, Wang B, Sun H, Chen L . Exposure to phthalates in patients with diabetes and its association with oxidative stress, adiponectin, and inflammatory cytokines. Environ Int. 2017; 109:53-63. DOI: 10.1016/j.envint.2017.09.002. View

Boberg J, Metzdorff S, Wortziger R, Axelstad M, Brokken L, Vinggaard A . Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology. 2008; 250(2-3):75-81. DOI: 10.1016/j.tox.2008.05.020. View

Goodman M, LaKind J, Mattison D . Do phthalates act as obesogens in humans? A systematic review of the epidemiological literature. Crit Rev Toxicol. 2014; 44(2):151-75. DOI: 10.3109/10408444.2013.860076. View

Zhang H, Chen J, Chen C, Wan H, Chen Y, Wang Y . Exposure to phthalates and cardiovascular diseases in Chinese with type 2 diabetes. Environ Sci Pollut Res Int. 2021; 28(41):58113-58122. DOI: 10.1007/s11356-021-14807-4. View

Zhu X, Yin T, Yue X, Liao S, Cheang I, Zhu Q . Association of urinary phthalate metabolites with cardiovascular disease among the general adult population. Environ Res. 2021; 202:111764. DOI: 10.1016/j.envres.2021.111764. View

Henning R . Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol. 2018; 14(6):491-509. DOI: 10.2217/fca-2018-0045. View

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2021; 183:109119. PMC: 11057359. DOI: 10.1016/j.diabres.2021.109119. View

Diamanti-Kandarakis E, Bourguignon J, Giudice L, Hauser R, Prins G, Soto A . Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009; 30(4):293-342. PMC: 2726844. DOI: 10.1210/er.2009-0002. View

10.

Tran V, Tindula G, Huen K, Bradman A, Harley K, Kogut K . Prenatal phthalate exposure and 8-isoprostane among Mexican-American children with high prevalence of obesity. J Dev Orig Health Dis. 2016; 8(2):196-205. PMC: 5332297. DOI: 10.1017/S2040174416000763. View

11.

Gerrits E, Landman G, Bilo H . Mortality trends in diabetes mellitus. JAMA Intern Med. 2015; 175(3):469. DOI: 10.1001/jamainternmed.2014.7985. View

12.

Gaston S, Tulve N . Urinary phthalate metabolites and metabolic syndrome in U.S. adolescents: Cross-sectional results from the National Health and Nutrition Examination Survey (2003-2014) data. Int J Hyg Environ Health. 2018; 222(2):195-204. PMC: 11780690. DOI: 10.1016/j.ijheh.2018.09.005. View

13.

Cassidy S, Trenell M, Anderson K . The cardio-metabolic impact of taking commonly prescribed analgesic drugs in 133,401 UK Biobank participants. PLoS One. 2017; 12(12):e0187982. PMC: 5718411. DOI: 10.1371/journal.pone.0187982. View

14.

Mariana M, Feiteiro J, Verde I, Cairrao E . The effects of phthalates in the cardiovascular and reproductive systems: A review. Environ Int. 2016; 94:758-776. DOI: 10.1016/j.envint.2016.07.004. View

15.

Mariana M, Cairrao E . Phthalates Implications in the Cardiovascular System. J Cardiovasc Dev Dis. 2020; 7(3). PMC: 7570088. DOI: 10.3390/jcdd7030026. View

16.

HOLEMANS K, Aerts L, Van Assche F . Lifetime consequences of abnormal fetal pancreatic development. J Physiol. 2003; 547(Pt 1):11-20. PMC: 2342610. DOI: 10.1113/jphysiol.2002.036582. View

17.

Sturgeon S, Flynn D, Kaiser A, Reeves K . Urinary levels of phthalate metabolites and cardiovascular disease mortality (NHANES, 1999-2008). Int J Hyg Environ Health. 2016; 219(8):876-882. DOI: 10.1016/j.ijheh.2016.07.006. View

18.

Calafat A, Koch H, Swan S, Hauser R, Goldman L, Lanphear B . Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res. 2013; 15(5):403. PMC: 3978629. DOI: 10.1186/bcr3494. View

19.

Gordon-Dseagu V, Shelton N, Mindell J . Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health Survey cohorts. J Diabetes Complications. 2014; 28(6):791-7. DOI: 10.1016/j.jdiacomp.2014.06.016. View

20.

Dales R, Kauri L, Cakmak S . The associations between phthalate exposure and insulin resistance, β-cell function and blood glucose control in a population-based sample. Sci Total Environ. 2017; 612:1287-1292. DOI: 10.1016/j.scitotenv.2017.09.009. View